BRIEF published on 07/17/2025 at 18:05, 11 months 30 days ago BIOSYNEX announces a decline in revenue for the first half of 2025 Restructuring Product Launches Turnover BIOSYNEX First Half Of 2025
BRIEF published on 05/06/2025 at 15:15, 1 year 2 months ago BIOSYNEX: Number of Shares and Voting Rights as of February 28, 2025 Share Capital Voting Rights Euronext Growth BIOSYNEX Health Diagnosis
BRIEF published on 04/23/2025 at 18:05, 1 year 2 months ago BIOSYNEX SA: 2024 Results and 2025 Reorganization Plan Financial Structure BIOSYNEX SA 2024 Results Export Growth Reorganization 2025
BRIEF published on 03/04/2025 at 18:05, 1 year 4 months ago BIOSYNEX: Declaration of the number of shares and voting rights Share Capital Voting Rights Actions BIOSYNEX Health Diagnosis
BRIEF published on 02/12/2025 at 08:05, 1 year 5 months ago BIOSYNEX successfully completes its capital increase Capital Increase Subscription BIOSYNEX Dilution Of Shareholders Oversubscription Rate
BRIEF published on 01/22/2025 at 07:05, 1 year 5 months ago Launch of the capital increase by BIOSYNEX SA Shareholders Capital Increase Subscription BIOSYNEX Preferential Subscription Right
BRIEF published on 01/13/2025 at 18:20, 1 year 6 months ago Growth and Restructuring: Biosynex in 2024 Restructuring Economic Growth Export Sales Pharmacy Division Diagnostic Division
BRIEF published on 12/19/2024 at 18:05, 1 year 6 months ago BIOSYNEX SA unveils its financial calendar for 2025 Financial Calendar Annual Results Turnover 2025 BIOSYNEX
BRIEF published on 12/02/2024 at 08:05, 1 year 7 months ago BIOSYNEX: Agreement in Principle for Financial Reorganization and Capital Increase Strategic Development Capital Increase Debt Restructuring BIOSYNEX Agreement In Principle
BRIEF published on 11/04/2024 at 18:05, 1 year 8 months ago BIOSYNEX SA: Declaration of Shares and Voting Rights Voting Rights Actions Transparency Financial Markets BIOSYNEX
Published on 07/17/2026 at 01:00, 2 hours 23 minutes ago RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 3 hours 23 minutes ago LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Published on 07/16/2026 at 16:21, 11 hours 2 minutes ago First Canadian Graphite Completes Phase I Exploration on Zone 13 Discovery and Expands Lands Package
Published on 07/16/2026 at 15:30, 11 hours 53 minutes ago Caldwell Announces Leadership Appointments for Industrial Practice and Caldwell Analytics
Published on 07/16/2026 at 15:30, 11 hours 53 minutes ago Resilient Energy Inc. Advances Commercial Rollout; Operations Enter Final Stage Ahead of Revenue Generation
Published on 07/17/2026 at 02:10, 1 hour 13 minutes ago VARON Highlights Summer Wellness with Portable Oxygen Solutions for Active Lifestyles
Published on 07/16/2026 at 23:10, 4 hours 13 minutes ago EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
Published on 07/16/2026 at 21:16, 6 hours 7 minutes ago Hertz Energy Advances Its Lake George Antimony-Tungsten Project and Summarizes Lithium Project
Published on 07/16/2026 at 20:59, 6 hours 24 minutes ago EQS-Adhoc: SMA publishes preliminary results for the second quarter of 2026 and raises full-year 2026 guidance
Published on 07/16/2026 at 20:39, 6 hours 44 minutes ago AUTODOC successfully optimises capital structure
Published on 07/16/2026 at 18:08, 9 hours 15 minutes ago Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 08:45, 18 hours 38 minutes ago Air Liquide invests over 160M USD in the U.S. to supply advanced chips manufacturing in Arizona
Published on 07/15/2026 at 17:45, 1 day 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026